Medical Journals

Polymorphisms in the E-cadherin (Cdh1) Gene Promoter and the Risk of Bladder Cancer.

Authors:
  • Kiemeney Lambertus A
  • van Houwelingen Kjeld P
  • Bogaerts Manon
  • Witjes J Alfred
  • Swinkels Dorine W
  • den Heijer Martin
  • Franke Barbara
  • Schalken Jack A
  • Verhaegh Gerald W

From: Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Department of Epidemiology and Biostatistics, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.

European journal of cancer (Oxford, England : 1990)

  • Publish Date: Dec 2006
  • ISSN: 0959-8049
  • Volume: 42
  • Issue: 18
  • Pages: 3219-27
  • Medium: Print
  • Language: English
  • Citation (JAMA): Kiemeney Lambertus A, van Houwelingen Kjeld P, Bogaerts Manon, et al. Polymorphisms in the E-cadherin (Cdh1) Gene Promoter and the Risk of Bladder Cancer.. Eur. J. Cancer Dec 2006;42:3219-27

Abstract

AIM: E-cadherin plays a role in carcinogenesis. For two genetic polymorphisms in the gene (CDH1) promoter, a reduced transcription has been reported: a C/A single nucleotide polymorphism (SNP) and a G/GA SNP at -160 bp and -347 bp, respectively, upstream of the transcriptional start site. We studied the association between both polymorphisms and the risk of bladder cancer. METHODS: One hundred and ninety-seven patients with bladder cancer and 344 population controls were genotyped and haplotyped for both SNPs. RESULTS: A borderline significantly increased risk for bladder cancer was found for A allele carriers (OR 1.36; 95% CI: 0.96-1.94). We did not find any association between the -347 G/GA SNP and bladder cancer. Haplotype analyses did not yield much stronger associations with bladder cancer than the -160 C/A genotype analyses. CONCLUSION: This study supports earlier suggestions that the -160 C/A SNP in the CDH1 promoter is a risk factor for bladder cancer.

Mesh Headings (Keywords): Adult, Aged, Aged, 80 and over, Cadherins, Gene Frequency, Genotype, Haplotypes, Humans, Male, Middle Aged, Polymorphism, Genetic, Risk Factors, Urinary Bladder Neoplasms


Check for Full Text / PubMed Unique Identifier (PMID): 16934975


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.